BINEX Co., Ltd. (KOSDAQ:053030)
17,190
-380 (-2.16%)
Jun 5, 2025, 3:30 PM KST
BINEX Revenue
BINEX had revenue of 39.79B KRW in the quarter ending March 31, 2025, with 33.92% growth. This brings the company's revenue in the last twelve months to 140.13B, up 2.78% year-over-year. In the year 2024, BINEX had annual revenue of 130.05B, down -16.00%.
Revenue (ttm)
140.13B
Revenue Growth
+2.78%
P/S Ratio
3.79
Revenue / Employee
227.48M
Employees
616
Market Cap
531.59B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 130.05B | -24.77B | -16.00% |
Dec 31, 2023 | 154.82B | -1.85B | -1.18% |
Dec 31, 2022 | 156.68B | 22.28B | 16.58% |
Dec 31, 2021 | 134.40B | 1.42B | 1.07% |
Dec 31, 2020 | 132.98B | 7.72B | 6.16% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,898.69B |
Celltrion | 3,662.23B |
ALTEOGEN | 151.65B |
Yuhan | 2,114.76B |
SK Biopharmaceuticals | 578.00B |
HLB Co., Ltd. | 74.64B |
PharmaResearch | 392.31B |
LigaChem Biosciences | 146.42B |